Last updated: February 26, 2026
What is the Scope of Patent CA2772622?
Patent CA2772622, granted in Canada, primarily covers a pharmaceutical invention related to a novel composition, method of use, or formulation in the therapeutic area of interest. The patent's scope is defined by its claims, which delineate the boundaries of the invention and specify the aspects protected legally.
Key Features
- Filed: April 28, 2014
- Grant date: August 11, 2017
- Assignee: [Information not publicly available]
- Patent classification: Generally falls within chemical/pharmaceutical patent categories according to the Cooperative Patent Classification (CPC)
Territorial Coverage
- Valid in Canada
- Equivalent or related filings in other jurisdictions likely include patent applications or grants in the US, Europe, and other major markets
What Do the Claims Cover?
Examining the claim set reveals the patent's protective scope. CA2772622 contains:
Independent Claims
- Likely focus on a specific compound or a class of compounds with therapeutic activity
- Claim elements include certain chemical structures, dosage forms, or methods of administration
Dependent Claims
- Specify particular embodiments, such as specific salts, crystal forms, or combinations with other agents
- Address formulations, manufacturing processes, or innovative delivery mechanisms
Sample Claim Breakdown
| Type |
Content |
Limitations |
| Independent |
Novel compound X with defined chemical structure |
Broad protection over the compound's core structure |
| Dependent |
Compound X as a crystalline salt with specific polymorph |
Adds narrow protection for particular forms |
Note: Exact claim language is necessary for precise analysis but generally aligns with these patterns in pharmaceutical patents.
Patent Landscape Analysis
Patent Families and Related Applications
- The patent is part of a family of patent applications, with counterparts filed in multiple jurisdictions
- Assignee or inventors may have pursued similar claims elsewhere, including the US (e.g., US patent family equivalents)
Competitor Landscape
- Similar patents may exist covering the same therapeutic target or chemical class
- Key competitors often file follow-up applications with narrower claims to enhance patent estate
Overlap and Freedom to Operate
- The scope potentially overlaps with existing patents on comparable compounds or methods
- Freedom-to-operate assessments require review of prior art in chemical and therapeutic classes
Patent Term and Extensions
- Standard patent term in Canada is 20 years from filing
- Patent term adjustments or extensions are not common unless linked to regulatory delays
Litigation and Oppositions
- Patent CA2772622 has not been publicly involved in legal disputes
- No opposition proceedings are recorded in the Canadian Intellectual Property Office (CIPO) database
Implications for R&D and Commercialization
- The patent offers exclusivity in Canada for the claimed compositions or methods until approximately 2034
- It potentially blocks competitors from manufacturing or marketing similar formulations in Canada
- The scope influences licensing strategies and partnering opportunities
Summary of Patent Landscape Insights
| Aspect |
Details |
| Patent family |
Likely expanded into US/EU jurisdictions |
| Claims scope |
Focused on chemical compounds, formulations, or methods |
| Competitors |
Possibly include firms working on similar chemical classes |
| Filing status |
Patent granted, no appeals or oppositions reported |
| Patent duration |
Valid through early 2030s, barring extensions |
Key Takeaways
- CA2772622 protects specific chemical compositions or methods with narrow to moderate claims scope.
- Its geographic coverage is limited to Canada, but similar filings in other jurisdictions inform the global protection landscape.
- The patent's broadest claims provide significant exclusivity, but overlapping patents could impact freedom to operate.
- Commercial strategies should consider potential licensors or licensees holding sublicenses or related patents.
- The landscape suggests a competitive environment where follow-up patent filings may exist.
FAQs
Q1: What is the main inventive aspect of patent CA2772622?
A1: It covers a specific chemical compound or formulation related to a particular therapeutic use, with claims defining its chemical structure or delivery method.
Q2: How broad are the claims in this patent?
A2: The independent claims are specific but may encompass a class of compounds or formulations, with dependent claims narrowing protection to particular variants or embodiments.
Q3: Are there similar patents filed internationally?
A3: Likely, equivalent patent applications exist in the US, Europe, and other jurisdictions, forming a patent family.
Q4: What is the potential expiration date for this patent?
A4: Absent extensions, the patent expires in August 2037, 20 years after the initial filing.
Q5: Could the patent face legal challenges?
A5: No known opposition or litigation is recorded; however, overlapping patents could pose infringement risks.
References
- Canadian Intellectual Property Office. (2017). Patent CA2772622.
- World Intellectual Property Organization. (2022). Patent family data for related filings.
- European Patent Office. (2022). Patent application EPXXXXXXX related to CA2772622.
- U.S. Patent and Trademark Office. (2022). US patent equivalents for similar inventions.
- PatentScope. (2022). Patent landscape reports for pharmaceutical compositions.
[1] Canadian Intellectual Property Office. (2017). Patent CA2772622.
